MediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in Brazil

MediPharm Labs expands its Brazilian presence where the medical cannabis market is estimated to be worth $198 million in 2024, serving over 670,000 patients.1 Products include full-spectrum, GMP sublingual oral solutions with extensive pharmaceutical validation and characterization. Teuto is one of Brazil’s largest pharmaceutical manufacturers of both generic and branded medicines, with an extensive portfolio of oncologic specialty drugs, […]